Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy
Authors
Keywords
-
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-04-16
DOI
10.1007/s12253-019-00659-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer
- (2018) Brandon A. Mahal et al. EUROPEAN UROLOGY
- Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer
- (2018) Hatem Abou-Ouf et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings
- (2018) Rakesh Shiradkar et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy
- (2018) Priscilla Léon et al. WORLD JOURNAL OF UROLOGY
- Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue
- (2018) Lindsey A. Vandergrift et al. Scientific Reports
- Overdetection of Recurrence after Radical Prostatectomy: Estimates Based on Patient and Tumor Characteristics
- (2014) J. Xia et al. CLINICAL CANCER RESEARCH
- Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
- (2014) G. Saretzki CURRENT PHARMACEUTICAL DESIGN
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- (2014) Emilie Lalonde et al. LANCET ONCOLOGY
- Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death
- (2013) Simeng Wen et al. CANCER TREATMENT REVIEWS
- Differences in the expression of telomerase and prostate-specific membrane antigen in non-advanced prostatic cancer
- (2013) Anna Gasinska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Expression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancer
- (2013) Elzbieta Luczynska et al. POLISH JOURNAL OF PATHOLOGY
- Microvessel density and expression of vascular endothelial growth factor in clinically localized prostate cancer
- (2013) Elżbieta Łuczyńska et al. POLISH JOURNAL OF PATHOLOGY
- Diagnostic and prognostic molecular biomarkers for prostate cancer
- (2011) Glen Kristiansen HISTOPATHOLOGY
- High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
- (2010) Sarah Minner et al. PROSTATE
- Contemporary Risk Profile of Prostate Cancer in the United States
- (2009) Yu-Hsuan Shao et al. JNCI-Journal of the National Cancer Institute
- Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress
- (2008) S. Ahmed et al. JOURNAL OF CELL SCIENCE
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
- (2008) Roy Vergis et al. LANCET ONCOLOGY
- Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development
- (2007) Udo Moehren et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now